BNBernd Niggemann

Bernd Niggemann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bernd Niggemann has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 October 2015
      • Vol. 35  (10) , 5277-85

    Gelsolin Is Associated with Longer Metastasis-free Survival and Reduced Cell Migration in Estrogen Receptor-positive Breast Cancer.

    by Anna-Maria Stock, Franziska Klee, Karolina Edlund, Marianna Grinberg, Seddik Hammad, Rosemarie Marchan, Cristina Cadenas, Bernd Niggemann, Kurt S Zänker, Jörg Rahnenführer, et al.

    Tumor cell migration is a prerequisite for metastasis formation. The role of the actin-modulating protein, gelsolin, in metastasis is controversial, as previous studies have reported associations with both worse and better prognosis. We analysed the association of gelsolin mRNA levels with metastasis-free survival in three cohorts (n=766) of patients with node-negative breast cancer. To determine its effect on migration, gelsolin expression was down-regulated as well as overexpressed in breast cancer cell lines. Higher gelsolin expression correlated with lower tumor stage and grade, and slower cell proliferation, and was associated with longer metastasis-free survival (hazard ratio (HR)=0.60, p<0.001) in patients with estrogen receptor-positive (ER(+)) erb-b2 receptor tyrosine kinase 2-negative (HER2(-)) tumors. Conversely, the opposite association was observed in those with ER(-)HER(-) tumors (HR=1.95, p=0.014). Down-regulation of gelsolin using siRNA in MCF-7 and MDA-MB-468 cells increased cell migration, whereas overexpression had the opposite effect. High gelsolin levels are associated with better prognosis in ER(+)HER2(-) breast cancer and a reduction in tumor cell migration.


  • Norepinephrine inhibits the migratory activity of pancreatic cancer cells

    by Anna-Maria Stock, Desmond G. Powe, Stephan A. Hahn, Gabriele Troost, Bernd Niggemann, Kurt S. Zänker, Frank Entschladen


  • Differential Involvement of Myosin II and VI in the Spontaneous and SDF- 1-induced Migration of Adult CD133+ Hematopoietic Stem/Progenitor Cells and Leukemic Cells

    by Jbireal M. Ali Jbireal, Thomas Dittmar, Bernd Niggemann, Johannes Fischer, Frank Entschladen

    Cell migration is an essential characteristic of life. However, the indispensable, physiological migration of embryonic and adult stem cells, leukocytes, and fibroblasts is opposed to the pathological migration of tumor cells during metastasis formation. Leukemic cells take a special position, since they combine characteristics of leukocyte and tumor cell migration. Although migration occurs in many variants with regard to dynamics and molecular mechanisms, myosin is generally needed to generate locomotory forces in all of the aformentioned cells. Our work aims to the understanding on the involvement of different myosin isotypes in the migration of leukocytes and leukemic cells at various stages of differentiation. By means of our three-dimensional, collagen-based migration assay, we investigated the involvement of nonmuscle myosin II and myosin VI in the migration of adult CD133+ hematopoietic stem/progenitor cells (HSPCs) as well as of four leukemic cell lines (Jurkat, Molt-4, NB-4, Dohh-2) and cells from leukemia patients. We show that the spontaneous, matrix-induced migration of CD133+ HSPCs solely depends on the activity of myosin VI, whereas the stromal cellderived factor (SDF)-1-induced migration requires both myosin isotypes. In contrast, leukemic cells engage both myosin isotypes for the spontaneous and the SDF-1-induced migration with varying proportions. Our previous studies have shown that the migration of differentiated leukocytes is exclusively based on non-muscle myosin II. We conclude that the proportionate involvement of non-muscle myosin II and myosin VI varies due to the differentiation state of the cells. The involvement of myosin VI decreases with the grade of differentiation, whereas the role of non-muscle myosin II increases.

  • Open Access

    Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism

    by Melanie J Voss, Mischa F Möller, Desmond G Powe, Bernd Niggemann, Kurt S Zänker, Frank Entschladen

    Background: Some breast cancer patients receiving anti-angiogenic treatment show increased metastases, possibly as a result of induced hypoxia. The effect of hypoxia on tumor cell migration was assessed in selected luminal, post-EMT and basal-like breast carcinoma cell lines. Methods: Migration was assessed in luminal (MCF-7), post-EMT (MDA-MB-231, MDA-MB-435S), and basal-like (MDA-MB-468) human breast carcinoma cell lines under normal and oxygen-deprived conditions, using a collagen-based assay. Cell proliferation was determined, secreted cytokine and chemokine levels were measured using flow-cytometry and a bead-based immunoassay, and the hypoxic genes HIF-1α and CA IX were assessed using PCR. The functional effect of tumor-cell conditioned medium on the migration of neutrophil granulocytes (NG) was tested. Results: Hypoxia caused increased migratory activity but not proliferation in all tumor cell lines, involving the release and autocrine action of soluble mediators. Conditioned medium (CM) from hypoxic cells induced migration in normoxic cells. Hypoxia changed the profile of released inflammatory mediators according to cell type. Interleukin-8 was produced only by post-EMT and basal-like cell lines, regardless of hypoxia. MCP-1 was produced by MDA-MB-435 and -468 cells, whereas IL-6 was present only in MDA-MB-231. IL-2, TNF-α, and NGF production was stimulated by hypoxia in MCF-7 cells. CM from normoxic and hypoxic MDA-MB-231 and MDA-MB-435S cells and hypoxic MCF-7 cells, but not MDA-MB-468, induced NG migration. Conclusions: Hypoxia increases migration by the autocrine action of released signal substances in selected luminal and basal-like breast carcinoma cell lines which might explain why anti-angiogenic treatment can worsen clinical outcome in some patients.


  • Open Access

    PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironment

    by Melanie J Voss, Bernd Niggemann, Kurt S Zänker, Frank Entschladen

    Background: Tumor cells interact with the cells of the microenvironment not only by cell-cell-contacts but also by the release of signal substances. These substances are known to induce tumor vascularization, especially under hypoxic conditions, but are also supposed to provoke other processes such as tumor innervation and inflammatory conditions. Inflammation is mediated by two organ systems, the neuroendocrine system and the immune system. Therefore, we investigated the influence of substances released by PC-3 human prostate carcinoma cells on SH-SY5Y neuroblastoma cells as well as neutrophil granulocytes and cytotoxic T lymphocytes, especially with regard to their migratory activity. Results: PC-3 cells express several cytokines and growth factors including vascular endothelial growth factors, fibroblast growth factors, interleukins and neurotrophic factors. SH-SY5Y cells are impaired in their migratory activity by PC-3 cell culture supernatant, but orientate chemotactically towards the source. Neutrophil granulocytes increase their locomotory activity only in response to cell culture supernantant of hypoxic but not of normoxic PC-3 cells. In contrast, cytotoxic T lymphocytes do not change their migratory activity in response to either culture supernatant, but increase their cytotoxicity, whereas supernatant of normoxic PC-3 cells leads to a stronger increase than that of hypoxic PC-3 cells. Conclusions: PC-3 cells release several signal substances that influence the behavior of the cells in the tumor's microenvironment, whereas no clear pattern towards proinflammatory or immunosuppressive conditions can be seen.


  • Open Access

    Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes

    by Carina Strell, Anne Sievers, Philipp Bastian, Kerstin Lang, Bernd Niggemann, Kurt S Zänker, Frank Entschladen

    Background: Neurotransmitters are important regulators of the immune system, with very distinct and varying effects on different leukocyte subsets. So far little is known about the impact of signals mediated by neurotransmitters on the function of CD8+T lymphocytes. Therefore, we investigated the influence of norepinephrine, dopamine and substance P on the key tasks of CD8+T lymphocytes: activation, migration, extravasation and cytotoxicity.Results: The activation of naïve CD8+T lymphocytes by CD3/CD28 cross-linking was inhibited by norepinephrine and dopamine, which was caused by a downregulation of interleukin (IL)-2 expressionviaErk1/2 and NF-κB inhibition. Furthermore, all of the investigated neurotransmitters increased the spontaneous migratory activity of naïve CD8+T lymphocytes with dopamine being the strongest inducer. In contrast, activated CD8+T lymphocytes showed a reduced migratory activity in the presence of norepinephrine and substance P. With regard to extravasation we found norepinephrine to induce adhesion of activated CD8+T cells: norepinephrine increased the interleukin-8 release from endothelium, which in turn had effect on the activated CXCR1+CD8+T cells. At last, release of cytotoxic granules from activated cells in response to CD3 cross-linking was not influenced by any of the investigated neurotransmitters, as we have analyzed by measuring the β-hexosamidase release.Conclusion: Neurotransmitters are specific modulators of CD8+T lymphocytes not by inducing any new functions, but by fine-tuning their key tasks. The effect can be either stimulatory or suppressive depending on the activation status of the cells.


  • Chronische Entzündungen – Rolle am Tumorgeschehen

    by Thomas Dittmar, Bernd Niggemann, Kurt S Zänker

    Die Erkenntnis, dass ein Zusammenhang zwischen chronischen Entzündungen und einem erhöhten Krebsrisiko besteht, wurde bereits vor mehr als 150 Jahren vom Berliner Mediziner Rudolph Virchow beschrieben. Heute wird vermutet, dass ca. 10-15 % aller humanen Krebserkrankungen auf chronische Entzündungsprozesse zurückzuführen sind, wobei die Ursachen sowohl auf humanpathogene Keime (z. B. Helicobacter pylori) als auch auf anorganische/organische Substanzen/Faktoren (Asbestfasern, Magensäure, Zigarettenrauch) zurückgeführt werden können. Chronisch entzündetes Gewebe stellt ein potenziell transformierendes Milieu dar, da es reich an Wachstumsfaktoren, Zytokinen und Chemokinen ist, welche die proliferatorische Aktivität von Zielzellen triggern, sowie an radikalischen Sauerstoff-/Stickstoffverbindungen, die bei hoher Konzentration Schädigungen der DNS bewirken. Durch die Faktor vermittelte bzw. inhärente Zellteilungsaktivität der Zielzellen, kombiniert mit mutagen wirkenden radikalischen Sauerstoff-/Stickstoffverbindungen, kann es zur Akkumulation von chromosomalen Aberrationen und nachfolgend zur malignen Transformation der Zielzellen kommen. Entgegen der alten Lehrmeinung, dass Krebs seinen Ursprung in somatischen Zellen hat, ist heute bekannt, dass die Ursprungszellen für maligne Transformationen Stammzellen (Gewebestammzellen bzw. rekrutierte Knochenmarkstammzellen) bzw. deren Progenitorzellen sind, aus denen die tumorinitiierenden Krebsstammzellen hervorgehen. So konnte z. B. anhand eines etablierten Mausmodells zur Analyse des durch H. felis induzierten Magenadenokarzinoms gezeigt werden, dass das neoplastische Gewebe aus rekrutierten Knochenmarkstammzellen hervorgegangen ist. Neben ihrer Rolle in der Karzinogenese sind chronische Entzündungsreaktionen darüber hinaus maßgeblich an der Progression von Tumorerkrankungen beteiligt. Fatal hierbei ist die symbiotische Beziehung zwischen tumorassoziierten Makrophagen (TAM) und Tumorzellen. TAM sind an sämtlichen Prozessen beteiligt, die eine erhöhte Malignität der Tumorerkrankung nach sich ziehen. Hierzu zählen die Neoangiogenese, die Proliferation sowie die Invasion und Metastasierung von Tumorzellen wie auch die Suppression von zytotoxischen T-Zellen. The connection between chronically inflamed tissues and an increased risk to get cancer was already described by Rudolph Virchow nearly 150 years ago. Today, we know that about 10 to 15 % of human cancers are attributed to chronic infections and/or inflammatory conditions caused by pathogens like Helicobacter pylori and/or inorganic/organic agents such as asbestos fibers, gastric acid or smoke. Chronically inflamed tissues are characterized by an aberrant mix of growth factors, cytokines and chemokines, which induce cell proliferation, as well as reactive oxygen and nitrogen species that will cause DNA damages. Thus, chronically inflamed tissues exhibit an increased cell transformation capacity because dividing cells could accumulate chromosomal aberrations, which ultimately can give rise to a malignant phenotype. To date, we know that cancer has its origin in cancer stem cells, which can originate from either adult tissue stem cells or committed progenitor cells. In case of chronically inflamed gastric tissue it was demonstrated that gastric cancer can originate from recruited bone marrow-derived stem cells. Chronically inflamed conditions do also play a role in tumor progression since tumor tissue resembles chronically inflamed tissues. Thereby, a pivotal role has been addressed to tumor-associated macrophages (TAMs). TAMs are stimulated by tumor cells and vice versa thus indicating a symbiotically relationship between these cellular entities. In fact, TAMs are participated in all mechanisms that increase tumor malignancy including neoangiogenesis, proliferation, invasion and metastasis as well as suppression of cytotoxic T lymphocytes.